Skip to main
University-wide Navigation

Results of Johnson & Johnson COVID-19 Vaccine Trial Announced

The Phase 3 randomized, double-blind, placebo-controlled clinical trial was designed to evaluate the safety and efficacy of a single vaccine dose of the Janssen investigational COVID-19 vaccine candidate versus placebo. Approximately 45,000 people participated worldwide. The combined UK, Baptist and Norton site was among the top enrolling sites in the world.

Why COVID-19 Vaccine Research Remains Critical

"While approved vaccines are able to prevent a COVID reinfection with a high effectiveness rate, it is still early on and we don't know how durable they are going to be in the long run. We also don’t know how effective these vaccines are at preventing asymptomatic spread. These questions are what researchers in my field will be looking at for many years to come."

UK Study Potentially Links Low Blood Amylin Level to Reduced Progression of Alzheimer’s Disease

Florin Despa says that a major scientific goal is to understand whether the same factors that are involved in age-related metabolic disorders such as type-2 diabetes may also play a role in the development and progression of cognitive decline and dementia.

New Study to Provide 1st In-Depth Look at Hip Pain in Patients With Marfan Syndrome

The research team will take a closer look at how the muscle weakness associated with Marfan syndrome leads to problems with hip joint muscle function, muscle morphology and gait mechanics. The exact association of these factors with the onset of hip joint pain and cartilage degeneration is unknown and of particular interest to the researchers.

UK Study Provides Evidence for a 7-Day Quarantine for University Students Exposed to COVID-19

A new University of Kentucky study provides direct evidence for a testing strategy that could be used to support a shortened period of quarantine for university students who are exposed to the virus but are asymptomatic.

Thaddeus Salmon named 2020-21 Bell Addiction Medicine Scholar

“I’m looking forward to enhancing screening and management of substance use disorders in our primary care practice at the Polk-Dalton Clinic. This will increase access to treatment for many patients, and we will also be able to improve education for our medical students and residents who rotate through the clinic.”

UK Researchers Advancing Wastewater Testing to Track COVID-19

“We have the expertise and equipment to advance testing procedures and understand more about the virus’ presence in wastewater—gaining knowledge that can help not only our local community, but also areas around the world that may lack testing infrastructure.”

You Can Make a Difference by a Taking a Short Survey about COVID-19

Anyone over the age of 18 is invited to complete a short survey from Wellness, Health, & You (WHY), an ongoing research project that seeks to understand how different life experiences affect wellbeing and health.

Vanderford Receives Kentucky Academy of Science’s Excellence in Science Education and Outreach Award

Vanderford, an assistant professor in the Department of Toxicology and Cancer Biology in the UK College of Medicine and assistant director for education and research at the UK Markey Cancer Center, received the award at the KAS Annual Conference on Nov. 6.

New Research Aims to Improve Health Among Rural Appalachians Through Personal Technology

The National Institutes of Health/National Heart Lung and Blood Institute recently awarded a five-year $3.8 million grant to the University of Kentucky to begin a new study aimed at improving diet and activity among rural Appalachian Kentuckians.